Patient-reported outcomes and satisfaction with gender-affirming hormone therapy among transgender and gender-diverse individuals in South Korea: A multicenter prospective study.

IF 8.4 2区 医学 Q1 PSYCHOLOGY, CLINICAL
International Journal of Transgender Health Pub Date : 2026-02-14 eCollection Date: 2026-01-01 DOI:10.1080/26895269.2026.2626839
Eun Sil Lee, Sun Young Lee, Ssirai Kim, Kuylhee Kim, Na-Hyun Hwang, Yehoon Choi, Hyein Chu, Jung-Won Yoon
{"title":"Patient-reported outcomes and satisfaction with gender-affirming hormone therapy among transgender and gender-diverse individuals in South Korea: A multicenter prospective study.","authors":"Eun Sil Lee, Sun Young Lee, Ssirai Kim, Kuylhee Kim, Na-Hyun Hwang, Yehoon Choi, Hyein Chu, Jung-Won Yoon","doi":"10.1080/26895269.2026.2626839","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Knowledge of gender-affirming hormone therapy (GAHT) among transgender and gender-diverse (TGD) individuals outside Western countries remains limited. This study aimed to investigate GAHT-related experiences and patient-reported outcomes and related factors among TGD individuals in South Korea.</p><p><strong>Methods: </strong>A multicenter prospective study was conducted at eight gender-affirming care-providing clinics in Korea. TGD individuals who underwent GAHT were included. An online survey was administered between January and October 2024. Demographic characteristics and satisfaction and self-perceived GAHT effects were measured on a Likert scale; regret was assessed on a 0 (no regret) to 100 (total regret) scale. Multivariable logistic regression analysis was conducted to investigate the associated factor with satisfaction.</p><p><strong>Results: </strong>Among 824 participants, 437 (53.0%), 253 (30.7%), 98 (11.9%), and 36 (4.4%) were trans women, trans men, non-binary individuals assigned male at birth (NB-AMAB), and non-binary individuals assigned female at birth (NB-AFAB), respectively. The median age was 28 years (interquartile range [IQR] 24-33). Median age at GAHT initiation was 24 years (IQR 21-29), and median duration was 2.9 years (IQR 1.1-5.8). Most respondents (90.7%) were satisfied with GAHT; 9.3% reported moderate-to-low satisfaction. Moderate-to-low satisfaction rate was the highest among NB-AMAB (16.3%) and lowest among trans men (5.9%). Approximately 80.8% reported no regrets. GAHT improved gender congruence (89.6%), gender expression (87.2%), quality of life (85.2%), self-esteem (82.3%), and mental health (82.1%).</p><p><strong>Discussion: </strong>Most TGD individuals who underwent GAHT in Korea were satisfied and exhibited a very low rate of regret. To improve the health and well-being of TGD individuals in Korea, accessibility to GAHT should be expanded.</p>","PeriodicalId":48480,"journal":{"name":"International Journal of Transgender Health","volume":"27 5","pages":"2740-2752"},"PeriodicalIF":8.4000,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13618088/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Transgender Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/26895269.2026.2626839","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Knowledge of gender-affirming hormone therapy (GAHT) among transgender and gender-diverse (TGD) individuals outside Western countries remains limited. This study aimed to investigate GAHT-related experiences and patient-reported outcomes and related factors among TGD individuals in South Korea.

Methods: A multicenter prospective study was conducted at eight gender-affirming care-providing clinics in Korea. TGD individuals who underwent GAHT were included. An online survey was administered between January and October 2024. Demographic characteristics and satisfaction and self-perceived GAHT effects were measured on a Likert scale; regret was assessed on a 0 (no regret) to 100 (total regret) scale. Multivariable logistic regression analysis was conducted to investigate the associated factor with satisfaction.

Results: Among 824 participants, 437 (53.0%), 253 (30.7%), 98 (11.9%), and 36 (4.4%) were trans women, trans men, non-binary individuals assigned male at birth (NB-AMAB), and non-binary individuals assigned female at birth (NB-AFAB), respectively. The median age was 28 years (interquartile range [IQR] 24-33). Median age at GAHT initiation was 24 years (IQR 21-29), and median duration was 2.9 years (IQR 1.1-5.8). Most respondents (90.7%) were satisfied with GAHT; 9.3% reported moderate-to-low satisfaction. Moderate-to-low satisfaction rate was the highest among NB-AMAB (16.3%) and lowest among trans men (5.9%). Approximately 80.8% reported no regrets. GAHT improved gender congruence (89.6%), gender expression (87.2%), quality of life (85.2%), self-esteem (82.3%), and mental health (82.1%).

Discussion: Most TGD individuals who underwent GAHT in Korea were satisfied and exhibited a very low rate of regret. To improve the health and well-being of TGD individuals in Korea, accessibility to GAHT should be expanded.

韩国跨性别和性别多样化个体中性别肯定激素治疗的患者报告结果和满意度:一项多中心前瞻性研究。
简介:在西方国家之外,变性人和性别多样性(TGD)个体对性别确认激素治疗(GAHT)的了解仍然有限。本研究旨在调查韩国TGD患者的gaht相关经历、患者报告的结果和相关因素。方法:在韩国八家性别确认护理诊所进行了一项多中心前瞻性研究。包括接受GAHT治疗的TGD患者。一项在线调查于2024年1月至10月进行。采用李克特量表测量人口统计学特征、满意度和自我感知的GAHT效应;后悔的评分从0(无后悔)到100(总后悔)。采用多变量logistic回归分析,探讨影响满意度的相关因素。结果:824名参与者中,跨性别女性437人(53.0%),跨性别男性253人(30.7%),跨性别男性98人(11.9%),跨性别男性36人(4.4%),非二元性别出生时为男性(NB-AMAB),非二元性别出生时为女性(NB-AFAB)。年龄中位数为28岁(四分位数间距[IQR] 24-33)。GAHT开始时的中位年龄为24岁(IQR 21-29),中位病程为2.9年(IQR 1.1-5.8)。大多数受访者(90.7%)对GAHT满意;9.3%的受访者满意度为中低。中低满意度以NB-AMAB最高(16.3%),跨性别男性最低(5.9%)。大约80.8%的人表示不后悔。GAHT改善了性别一致性(89.6%)、性别表达(87.2%)、生活质量(85.2%)、自尊(82.3%)和心理健康(82.1%)。讨论:在韩国,大多数接受了GAHT治疗的TGD患者都很满意,并且表现出非常低的后悔率。为了改善韩国TGD个人的健康和福祉,应扩大获得GAHT的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.40
自引率
10.90%
发文量
27
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书